Drug Interaction Report

Buprenorphine and Trospium / Xanomeline: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Buprenorphine

Belbuca Brixadi Buprenex BuTrans Simbadol Sublocade Zorbium
+

Trospium / Xanomeline

Cobenfy
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 633 documented Buprenorphine interactions, 601 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Buprenorphine and Cobenfy (trospium) can both slow the gut and bladder, so together they raise the chance of severe constipation or urinary retention. Watch for these symptoms and report them, but keep taking both as prescribed while your care team monitors you.

You're taking buprenorphine (an opioid used for pain or opioid dependence) along with Cobenfy, which contains trospium, a medicine that can slow down the gut and bladder. Both of these can make your bowels move more slowly and make it harder to empty your bladder.

When they're combined, that slowing effect can add up. In rare cases this could lead to severe constipation or even a condition where the bowel stops moving properly, or trouble passing urine. The good news is this is a possible risk, not a sure thing. Watch for hard stools, bloating, belly pain, or trouble urinating, and let your care team know. They can manage this easily by keeping an eye on things.

Effect: Additive anticholinergic and opioid effects on GI and urinary smooth muscle may increase the risk of severe constipation, urinary retention, and paralytic ileus.

  • Mechanism: Buprenorphine reduces GI motility via mu-opioid effects; trospium (Cobenfy) exerts antimuscarinic effects that further slow gastric/intestinal motility and impair bladder emptying. Effects are additive (PD interaction), not metabolic.
  • Direction: Additive reduction in motility; neither agent is enzymatically dependent here.
  • Evidence: Theoretical; severity rated major.
  • Management: Monitor for reduced gastric motility, abdominal distension, and urinary retention. Consider bowel regimen and dose individualization by the care team.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of paralytic ileus

Interaction Deep Dive

When buprenorphine is given together with an anticholinergic agent, the combination may lead to urinary retention or to severe constipation that progresses to paralytic ileus. In patients receiving buprenorphine alongside anticholinergic drugs, watch for indications of urinary retention or diminished gastric motility1.

Why it happens (mechanism)

Additive effects on gastric motility

How to manage this interaction

Keep taking both medicines as prescribed unless your prescriber tells you otherwise. This is a possible (theoretical) risk, and your care team can manage it.

  • Watch for severe constipation, bloating, belly pain, or no bowel movement, and for trouble urinating or a full-feeling bladder.
  • Report these symptoms promptly to your pharmacist or prescriber.
  • Your team may monitor you more closely and can adjust and individualize your regimen if needed.
  • Ask your pharmacist about staying hydrated and whether a stool softener or laxative plan makes sense for you.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Buprenorphine and Trospium / Xanomeline together?

Buprenorphine and Cobenfy (trospium) can both slow the gut and bladder, so together they raise the chance of severe constipation or urinary retention. Watch for these symptoms and report them, but keep taking both as prescribed while your care team monitors you. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Buprenorphine and Trospium / Xanomeline interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Buprenorphine and Trospium / Xanomeline interaction managed?

Keep taking both medicines as prescribed unless your prescriber tells you otherwise. This is a possible (theoretical) risk, and your care team can manage it. Watch for severe constipation, bloating, belly pain, or no bowel movement, and for trouble urinating or a full-feeling bladder. Report these symptoms promptly to your pharmacist or prescriber. Your team may monitor you more closely and can ad… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Buprenorphine or Trospium / Xanomeline need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.